Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
Genobio Successfully Registered CE-IVDR for Its Instruments
Tianjin, China – October 7, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and...
Era Biology has launched a new product series which is Chemiluminescence Immunoassay (CLIA) detection kit for detecting inflammation and bacterial infections. The kit is run on Full-Automatic Chemi...
A few days ago, ERA BIO (Suzhou) New Product Launch Conference and Liandong U Valley Signing Ceremony was successfully completed in Suzhou, Jiangsu! At this press conference, Yirui Biological rele...
Era Biology will host global live webinar at 12th July. Due to the fact that WHO has declared that antimicrobial resistance (AMR) is one of the top 10 global public health threats facing humanity. ...